Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against DBV Technologies S.A. (DBVT)
DBV Technologies S.A. - American Depositary Shares (DBVT)
US:NASDAQ Investor Relations:
dbv-technologies.com/en/investor-relations
Company Research
Source: Business Wire
LOS ANGELES--(BUSINESS WIRE)-- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the March 18, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased DBV Technologies S.A. (“DBV Technologies” or the “Company”) (NASDAQ: DBVT) securities between February 14, 2018 and December 19, 2018, inclusive (the “Class Period”). DBV Technologies investors have until March 18, 2019 to file a lead plaintiff motion. If you are a shareholder who suffered a loss, click here to participate. On December 19, 2018, DBV Technologies revealed that, following discussions with the U.S. Food and Drug Administration (FDA), its Biologics License Application (BLA) for Viaskin Peanut was voluntarily withdrawn. According to the Company, the FDA communicated that “the level of detail with regards to data on manufacturing and quality controls was insufficient
Show less
Read more
Impact Snapshot
Event Time:
DBVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DBVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DBVT alerts
High impacting DBV Technologies S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
DBVT
News
- DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Egg Allergy Drug Pipeline Research 2024 Featuring Aimmune Therapeutics, DBV Technologies, and ASIT Biotech [Yahoo! Finance]Yahoo! Finance
- DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Peanut Allergy Drug Landscape Analysis Report 2024: Comprehensive Insights of 12+ Companies and 15+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024GlobeNewswire
DBVT
Earnings
- 10/31/23 - Miss
DBVT
Analyst Actions
- 2/21/24 - HC Wainwright
DBVT
Sec Filings
- 4/8/24 - Form PRE
- 3/11/24 - Form 4
- 3/8/24 - Form 8-K
- DBVT's page on the SEC website